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Abstract
Obesity and cigarette smoking are correlated through complex relationships. Common
genetic causes may contribute to these correlations. In this study, we selected 241 loci
potentially associated with body mass index (BMI) based on the Genetic Investigation of
ANthropometric Traits (GIANT) consortium data and calculated a BMI genetic risk score
(BMI-GRS) for 17,037 individuals of European descent from the Oncoarray Project of the
International Lung Cancer Consortium (ILCCO). Smokers had a significantly higher BMIGRS than never-smokers (p = 0.016 and 0.010 before and after adjustment for BMI, respectively). The BMI-GRS was also positively correlated with pack-years of smoking (p<0.001)
in smokers. Based on causal network inference analyses, seven and five of 241 SNPs were
classified to pleiotropic models for BMI/smoking status and BMI/pack-years, respectively.
Among them, three and four SNPs associated with smoking status and pack-years
(p<0.05), respectively, were followed up in the ever-smoking data of the Tobacco, Alcohol
and Genetics (TAG) consortium. Among these seven candidate SNPs, one SNP
(rs11030104, BDNF) achieved statistical significance after Bonferroni correction for multiple
testing, and three suggestive SNPs (rs13021737, TMEM18; rs11583200, ELAVL4; and
rs6990042, SGCZ) achieved a nominal statistical significance. Our results suggest that
there is a common genetic component between BMI and smoking, and pleiotropy analysis
can be useful to identify novel genetic loci of complex phenotypes.

Introduction
Both obesity and cigarette smoking are risk factors for many human diseases, including multiple cancers.[1–4] There are complex sources of correlations between smoking behavior and
obesity.[5,6] In general, current smokers tend to have a lower body mass index (BMI) than
never-smokers, while smoking cessation is associated with weight gain.[7–9] The reasons for
the association between BMI and smoking status may involve smoking-induced appetite suppression via neural pathways [10] and increased energy expenditure via energy-regulating hormonal feedback loops.[11,12] On the other hand, heavy smokers tend to have a greater BMI
than light smokers; an observation that is seemingly contradictory to the metabolic effects of
smoking,[7,13] but may be partially attributed to the unhealthy behaviors associated with
heavy smoking. Another reason for the correlation between smoking behavior and obesity is
that there may be common underlying biological causes. There is growing evidence suggesting
that obesity may be partially due to addiction to food.[14,15] One plausible common mechanism for obesity and smoking is brain reward effects arising from neuronal activity within the
dopamine system.[16] In any case, the reasons for the relationship between BMI and smoking
behavior remain uncertain.
Shared genetic susceptibility may offer another explanation for the correlation between
obesity and smoking. Both smoking and obesity have significant genetic components. In the
past, large-scale genome-wide association studies (GWAS) on obesity or variables related to
smoking characteristics (e.g., smoking status, age started smoking, and pack-years of smoking,
etc) have successfully identified multiple loci associated with these phenotypes.[17–25] Yet,
total variation in obesity or smoking traits explained by these GWAS loci is still limited.
[20,26–29] The remaining genetic variants still need to be identified. It was estimated that the
genetic correlation between smoking status and BMI was 0.20.[30] In a previous study in
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Iceland, the genetic risk score (GRS) of 32 common variants identified in GWAS of BMI was
associated with smoking initiation and the number of cigarettes smoked per day (CPD), suggesting that smoking and BMI may share common genetic components.[31] However, this
study in Iceland only observed correlations of BMI associated SNPs with smoking variables,
without accounting for possible causal relationships between SNPs, BMI and smoking variables. We hypothesized that analyzing pleiotropic effects on BMI and smoking behavior may
discover novel genetic loci, otherwise undiscovered in GWAS with stringent genome-wide significance, which in turn would further elucidate genetic architectures underlying both smoking behavior and obesity. In this study, leveraging existing genotyping, BMI, and smoking data
from a lung cancer consortium, we confirmed the association between the BMI-GRS and
smoking-related variables with adjustment for BMI and important covariates, and used causal
network inference to identify potential genetic loci with pleiotropic effects on both BMI and
smoking-related phenotypes.

Materials and methods
Study population
The International Lung Cancer Consortium (ILCCO) was established in 2004 with the goal of
sharing comparable research data and maximizing research efficiency (http://ilcco.iarc.fr). To
further characterize cancer genetic architecture of common cancers, a custom OncoArray
(http://oncoarray.dartmouth.edu) genotyping chip that includes 550K markers was designed
to genotype samples in collaboration with other cancer consortia under The National Cancer
Institute (NCI) initiative on the Genetic Associations and Mechanisms in Oncology (GAMEON). In this study, we analyzed OncoArray genotypic data of 36,000 subjects of European
descent in ILCCO; among them, 17,037 provided individual epidemiological data and were of
European descent.

OncoArray genotyping, quality control and imputation
The GAME-ON OncoArray chip was previously described.[32] In brief, it includes a GWAS
backbone and a customized panel for dense mapping of known susceptibility regions, rare variants from sequencing experiments, pharmacogenetic markers and cancer related traits including smoking and BMI. The genotyping quality control of Oncoarray data was previously
described.[33] After filtering out SNPs by success rate and genotype distribution deviation
from the expected by Hardy-Weinberg equilibrium, 517,482 SNPs were available for analysis.
Standard quality control procedures were used to exclude underperforming samples (2,408),
unexpected duplicated or related samples (2,411), samples with sex error (316) and non-Caucasians (8,240). After quality control, 17,037 subjects with full information on both BMI and
smoking status, and other important covariates (age, sex, study sites, and lung cancer status)
were kept for analysis. Genotype data were imputed by the GAME-ON data coordinating center for all scans for over 10 million SNPs using data from the 1000 Genomes Project (Phase 3,
October 2014) as reference.[34,35]. The data were imputed in a two-stage procedure using
SHAPEIT [36] to derive phased genotypes, and IMPUTEv2 to perform imputation of the
phased data. [35] Genotypes were aligned to the positive strand in both imputation and actual
genotyping.

SNP selection and derivation of the BMI-GRS
We first identified a large set of 4,961 SNPs associated with BMI with p<10−5 based on results
from the Genetic Investigation of ANthropometric Traits (GIANT) consortium, a large
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collaborative GWAS on human body size and shape. We then pruned SNPs by applying a
threshold value of r2 = 0.2 and requiring selected SNPs at least 500Kb apart to reduce redundancy and obtained a subset of 241 independent SNPs that were at least 500Kb apart (S1
Table). To calculate the BMI-GRS, each SNP was recoded as 0, 1, or 2 according to the number
of risk alleles (BMI increasing alleles). The BMI-GRS was calculated using the equation: GRS =
(weight1×SNP1 + weight 2×SNP2 + . . . + weight n×SNPn), where n is the total number of
SNPs. Both un-weighted and weighted BMI-GRSs were calculated in which the weight is 1 for
all SNPs and the weight is the β coefficient of each individual SNP on BMI derived from
GIANT for the un-weighted and weighted GRS, respectively. The results of un-weighted and
weighted GRS were largely similar and we presented un-weighted BMI-GRS in the Results. To
examine the robustness of the results based on the BMI-GRS of our selected SNPs, we also calculated the BMI-GRS based on 97 BMI-associated SNPs which reached genome-wide significant levels (P< 5×10–8) in the GIANT BMI GWAS including up to 322,154 European
descents and 17,072 non-European descents [37].

Statistical analysis
Age, sex, smoking statuses, pack-years, BMI, and BMI categories were compared between lung
cancer statuses by student t-test and Chi-square test for categorical variables. All statistical
tests are two-sided. The analyses were performed using R (v2.6).

Association of BMI with smoking phenotypes
Linear regression model was applied for comparison of BMI among individuals with different
smoking categories (never-smokers, current smokers and ex-smokers) with adjustment for
age, sex, and study sites. Adjusted means of BMI of individuals with different smoking categories and their 95% confidence intervals (CIs) were calculated using the lm function in the statistical software R with a fixed intercept of zero. Additional stratification analyses by lung
cancer status were performed.

Association of the BMI-GRS with BMI and smoking phenotypes
Linear regression was also used to compare the BMI-GRS between different BMI categories
(underweight, <18.5; Normal, 18.5–24.9; Overweight, 25.0–29.9; and Obese,  30) by adjusting for age, sex, study sites, and top four genetic principal components. Although our analyses
were performed only for participants of European descent, study sites and top four genetic
principle components generated using common SNPs were included in the regression models
for BMI-GRS in order to further limit the effects of any possible cryptic population stratification that might cause inflation of test statistics. Trend tests were performed by analyzing the
BMI categories as a continuous variable in the regression model. A similar regression analysis
was also performed to compare the BMI-GRS between individuals with different smoking categories (never-smokers, current-smokers, and ex-smokers). Partial correlation coefficients
between the BMI-GRS and pack-years of smoking were estimated by Pearson correlation coefficients of their residuals from linear regression models after adjusting for age, sex, study sites,
and top four genetic principal components. Additional stratification analyses were performed
by lung cancer status.

Identifying candidate pleiotropic SNPs for BMI and smoking phenotypes
We used a causal network inference model to identify possible pleiotropic SNPs for both BMI/
pack-years and BMI/smoking status (smokers versus non-smokers), respectively.[38] We
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Fig 1. Twelve possbile directed acyclic graphs (DAGs) of one SNP, BMI and pack-years (PY) of
smoking. Possible DAGs between one SNP, BMI and PY. The DAGs are categorized into 4 groups. SNPs in
Category 1 (DAGs of 1, 2, and 3) do not have effects on either BMI or pack-years. SNPs in Category 2 (DAGs
of 4, 5, and 6) have direct effects on BMI, but not PY. SNPs in Category 3 (DAGs of 7, 8, and 9) have direct
effects on PY, but not BMI. SNPs in Category 4 (DAGs of 10, 11, and 12) have pleiotropic effects on BMI and
PY.  represents models that are not differentiable.
https://doi.org/10.1371/journal.pone.0185660.g001

describe the approach here using BMI and pack-years as an example. A similar approach was
used to identify pleiotropic SNPs for BMI and remaining smoking traits. Specifically, we modeled 12 possible directed acyclic graphs (DAGs) of the genotype value of a SNP on BMI and/or
pack-years (Fig 1). We classified these DAGs into four categories: (1) the SNP did not have
effects on either BMI or pack-years, (2) the SNP had direct effects on BMI, but not pack-years,
(3) the SNP had direct effects on pack-years, but not BMI, and (4) the SNP had pleiotropic
effects on both BMI and pack-years.
Based on a given DAG, we fit two linear regression models for BMI and pack-years, respectively, with adjustment for sex, age, study sites, and genetic principal components (PCs). For
example, two linear regression models for the DAG of SNP ! pack-years ! BMI (DAG 8
with gentic effects on pack-years only) are
BMI  Age þ Sex þ Study Sites þ PCs þ Pack years;
Pack years  Age þ Sex þ Study Sites þ PCs þ SNP:
To identify the model that was the most supported by the data, we calculated AIC for each
DAG
2 loglik ðRegression Model 1Þ

2 loglik ðRegression Model 2Þ þ 2 number of edges:

We then compared the minimum AIC values of four categories. SNPs with at least 2 of the
minimum AIC value of category 4 (model 10, 11, or 12) less than other categories were further
examined for their association with pack-years. Similar analyses were performed for smoking
status using logistic regression. Those SNPs that achieved a nominal statistical significance
(p<0.05) were considered as candidate pleiotropic SNPs, and further validated for their associations with ever-smoking using the independent database from TAG (The Tobacco, Alcohol
and Genetics) consortium.(https://www.med.unc.edu/pgc/results-and-downloads)
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Results
Characteristics of the study population
In our analysis, 17,037 subjects of European descent from 17 study sites had full information
on both BMI and smoking status, and other important covariates (age, sex, study sites, and
lung cancer status). As expected, compared to the controls, lung cancer cases were older, had a
higher proportion of smokers, and were slightly leaner (Table 1).

Association of BMI and smoking variables
We compared BMI levels among never-smokers, ex-smokers, and current smokers. As expected
and as compared to never-smokers, ex-smokers had a significantly higher BMI (difference from
never-smokers = 0.39 kg/m2, p = 2.64×10−4), while current smokers were leaner (difference
from never-smokers = -1.08 kg/m2, p = 8.20×10−24) after adjustment for age, sex and study
sites. Such differences in BMI by smoking status were similar for cases and controls (Fig 2).
BMI and pack-years of smoking were positively correlated in both current smokers and exsmokers after adjustment for age, sex and study sites, and the correlations were stronger in exsmokers than those in current-smokers (Table 2). Specifically, the partial coefficient of packyears of smoking and BMI was 0.054 (95%CI 0.027–0.075) and 0.112 (95%CI 0.088–0.136) for
current smokers and ex-smokers, respectively. The correlations between BMI and pack-years
were similar for cases and controls.

Association of the BMI-GRS with BMI
We first confirmed if the BMI-GRS based on 241 SNPs identified in GIANT was associated
with BMI in the OncoArray Project population. Comparing the BMI-GRS of individuals in
different BMI categories with adjustment for age, sex, study sites, genetic principal components, smoking types, and pack-years (Fig 3), we found that the BMI-GRS significantly
increased from the categories underweight (BMI<18.5), to normal weight (BMI 18.5–24.9), to
Table 1. Characteristics of 17,037 European-descent subjects in the OncoArray Project and epidemiologic data.
Cases

Controls

9,633

7,404

Male (%)

5,461 (56.7)

42,71 (57.7)

0.199

Age (sd)

65.2 (10.2)

61.1 (10.1)

<0.001

1,101 (11.4)

2,353 (31.8)

<0.001

N

P-values

Smoking type (%)
Never-smokers
Ex-smokers

3,934 (40.8)

2,782 (37.6)

Current smokers

4,598 (47.7)

2,269 (30.6)

47.8 (31.3)

33.1 (26.5)

<0.001

26.3 (4.9)

26.9 (4.8)

<0.001

268 (2.8)

66 (0.9)

Normal (18.5–24.9)

3,862 (40.1)

2,708 (36.6)

Over weight (25–29.9)

3,684 (38.2)

3,154 (42.6)

Obese (30)

1,819 (18.9)

1,476 (19.9)

Pack-years of smoking among smokers (sd)
BMI, kg/m2 (sd)
BMI categories (kg/m2)
Under weight (<18.5)

<0.001

The Basic characteristics of the subjects were described as mean (sd) for continuous variables, and number
(proportion, %) for category variables. The p-values were obtained by student t-test for continuous variables
and Çhi-square test for category variables.
https://doi.org/10.1371/journal.pone.0185660.t001
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Smoking Status
ex-smokers

current smokers

20

25

BMI

30

35

never-smokers

Cases

Controls

Total

Fig 2. Adjusted means of BMI (95% CIs) for never-smokers, ex-smokers, and current smokers with adjustment for age, sex, and study sites. Bar
represents mean±s.d.
https://doi.org/10.1371/journal.pone.0185660.g002

overweight (BMI 25–29.9), and to obese (BMI 30) with ptrend = 8.40×10−74. Similar associations between the BMI-GRS and BMI categories were found in cases and controls (ptrend =
1.75×10−39 and p trend = 5.96×10−37 for cases and controls, respectively).

Association of the BMI-GRS with smoking phenotypes
The BMI-GRS of smokers that include both ex-smokers and current smokers, was first compared with that of never-smokers. Smokers had a significantly higher BMI-GRS than neverTable 2. Partial correlations between BMI and pack-years of smoking by smoking status.
Current Smokers

Ex-smokers

n

Coef

95%CI

P

N

Coef

95%CI

P

6,577

0.054

0.027–0.075

<0.001

6,245

0.112

0.088–0.136

<0.001

Cases**

4,396

0.052

0.023–0.082

<0.001

3,682

0.106

0.074–0.138

<0.001

Controls**

2,181

0.072

0.030–0.114

<0.001

2,563

0.140

0.102–0.178

<0.001

All*

A table for the partial correlation coefficients between BMI and pack-years in smokers.
* For all subjects, the analysis was adjusted for age, sex, study sites and disease status.
** For cases and controls, the analyses were adjusted for age, sex, and study sites.
https://doi.org/10.1371/journal.pone.0185660.t002
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80

BMI categories
<18.5

18.5−24.9

25−29.9

>=30

70

BMI−GRS

60

50

p= 1.75x10−39

p= 5.96x10−37

p= 8.40x10−74

40

30
Cases

Controls

Total

Fig 3. Adjusted means of the BMI-GRS (95% CIs) by BMI category after adjustment for age, sex, study sites, genetic principal components,
smoking status, and pack-years of smoking. Bar represents mean±s.d.
https://doi.org/10.1371/journal.pone.0185660.g003

smokers (regression coefficient of ex-smokers: 0.516, p-value = 0.016) before adjustment for
BMI. After further adjustment for BMI, the association between the BMI-GRS and smoking
was strengthened (regression coefficient 0.545, p-value = 0.010). Ex-smokers and current
smokers were then compared separately with that of never-smokers. Ex-smokers and current
smokers had a similar BMI-GRS (regression coefficient 0.059, p-value = 0.750), but both of
them had a significantly higher BMI-GRS than never-smokers (regression coefficient of exsmokers: 0.490, p-value = 0.032; regression coefficient of current smokers: 0.549, p-value =
0.021) before adjustment for BMI. After further adjustment for BMI, the association between
the BMI-GRS and current smoking was strengthened (regression coefficient 0.838, p-value =
3.9×10−4), while the association between the BMI-GRS and ex-smoking was somewhat attenuated (regression coefficient 0.321, p-value = 0.157). The association patterns based on different
BMI-GRSs were largely consistent (S2 Table). The results were also similar when analyses were
stratified by lung cancer status.
There was also a significantly positive association between the BMI-GRS and pack-years of
smoking among smokers (Table 3). The associations were similar in cases and controls. After
stratification by smoking status, the association between the BMI-GRS and pack-years tended
to be stronger in current smokers (correlation coefficient 0.024, p = 0.049) than in ex-smokers
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Table 3. Partial correlations between pack-years of smoking and BMI-GRS.
Category*

Coef

95%CI

p-value

Total (n = 12,822)**

0.022

0.004–0.039

0.014

Current smokers (n = 6,575)

0.024

0.0001–0.048

0.049

Ex-smokers (n = 6,245)

0.009

-0.016–0.034

0.472

Cases (n = 8,078)

0.018

-0.004–0.040

0.109

Controls (n = 4,744)

0.031

0.003–0.060

0.030

Stratified by smoking categories**

Stratified by disease status***

*The partial correlation coefficients between BMI-GRS and pack-years were calculated in smokers.
** The correlation coefficients were adjusted for age, sex, BMI, study sites, genetic principal components,
and disease status.
*** The correlation coefficients were adjusted for age, sex, BMI, study sites, and genetic principal
components.
https://doi.org/10.1371/journal.pone.0185660.t003

(correlation coefficient 0.009, p = 0.472). The results based on different BMI-GRSs were largely
consistent (S3 Table).

Identifying pleiotropic SNPs for both BMI and smoking status
The above analyses suggested that among the 241 SNPs composed of the BMI-GRS (or in linkage disequilibrium with the 241 SNPs), there may be some pleiotropic SNPs that have direct
effects on smoking and BMI. To identify the pleiotropic loci (DAGs 10, 11, or 12 in Fig 1),
we first used network inference to determine the possible causal models of 241 SNPs. In total,
five SNPs were classfied into category four to be pleiotropic for both BMI and pack-years of
smoking, and seven SNPs were classfied into category four to be pleiotropic for both BMI and
smoking by network inference. We then examined the associations of each of these SNPs with
BMI and pack-years of smoking (or smoking status) with adjustment for age, sex, study sites,
genetic principal components and lung cancer disease status. (Fig 4). There were four and
three SNPs associated with pack-years of smoking and smoking status with p<0.05, respectively (Table 4). The SNPs classified as Category 4 and associated with smoking status or packyears with a nominal significance (p<0.05) were considered as candidate SNPs of pleiotropy.
The associations of these candidate pleiotropic SNPs with BMI were quite similar with and
without adjustment for pack-years or smoking status (S4 Table). We validated these SNPs
using data from the TAG consortium. Of the total of seven candidate pleiotropic SNPs for
BMI and pack-years or smoking status, rs11030104 (BDNF) was associated with ever-smoking
in TAG data after Bonferroni correction (p = 0.002), and rs13021737 (TMEM18), rs11583200
(ELAVL4) and rs6990042 (GCZ) achieved a nominal significance of 0.05 (p-values were 0.018,
0.008, and 0.043, respectively). Another interesting SNP that achieved a nominal significance
in TAG data (p = 0.020) was rs12016871 (MTIF3), but it did not achieve statistical significance
with smoking status in the OncoArray Project dataset (p = 0.161).

Discussion
In summary, we calculated the BMI-GRS for subjects who had OncoArray data of ILCCO
using 241 common SNPs potentially associated with BMI and demonstrated that the BMI-GRS
was associated with increased propensity to smoke as well as elevated pack-years after adjusting for the potential confounding effects of BMI. These results were consistent with those from
a previous study in Iceland in which the GRS of 32 SNPs identified in GWAS was found to be
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pleiotropic with further validation in TAG.
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associated with two smoking phenotypes, smoking initiation and the number of cigarettes
smoked per day. The observed associations between the BMI-GRS and smoking variables
could not be due to confounding of BMI, because the association of the BMI-GRS with smoking varaibles remained statistically significant after adjustment for BMI. Moverover, the
BMI-GRS was positively associated with current smoking, which was opposite to what would
be expected if the association between BMI-GRS and current smoking was due to the confounding effects of BMI, as current smoking and BMI was negatively correlated. Instead, the
associations between BMI-GRS and smoking indicate that some loci that composed the
BMI-GRS may directly contribute to smoking behavior, and may have pleiotropic effects on
both BMI and smoking variables.
Using causal network inference, we identified 4 loci that may have pleitropic effects on BMI
and pack-years of smoking and 3 loci with potential pleitropic effects on BMI and smoking
status. Among them, one locus (BDNF) achieved a statistical significance after Bonferroni correction (p<0.007), and three loci (TMEM18, ELAVL4, and SGCZ) achieved a nominal significance (p<0.05). in ever-smoking data from the TAG consortium. The result of BDNF (brain
derived neurotrophic factor) locus on chromosome 11 was consistent with prior studies that
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population (p<0.05) and with ever-smoking data of TAG consortium with a nominal significance of p<0.05.

ever-smoking in TAG are also presented. SNPs in the shadow were statistically signficant for the association with pack-years of smoking or smoking status in the OncoArray Project

The SNPs presented in this table were classified as Categoriy four (DAGs of 10,11,12 in Fig 1). The association directions and p-values of these SNPs with BMI in GIANT and with
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Table 4. SNPs with pleiotropic effects on BMI and smoking varibles among 241 SNPs composed of the BMI-GRS.
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had shown strong associations of this locus with BMI [18,39] and various smoking phenotypes.[17] Evidence from epidemiological studies [40] and animal studies [41] also indicate
associations of BDNF gene with other substance abuse related disorders, eating disorders, and
schizophrenia. The protein BDNF belongs to a neurotrophin family growth factors [42] and is
the most abundant of the neurotrophins in the brain with high concentrations in the hippocampus and cerebral cortex.[43,44] BDNF expression in the brain is regulated by the serotonergic[45] and the dopaminergic[46] neurotransmitter systems which are known to be
involved in nicotine use, addictive behaviors, mood and food intake. [47–50]
The TMEM18 (transmembrane protein 18) locus is another known GWAS locus of BMI.
[19] The Icelandic study that examined 32 GWAS loci of BMI had found significant associations of TMEM18 with both smoking initiation and cigarettes per day, an observation that was
consistent with what we found [31]. The function of TMEM18 is largely unknown. TMEM18 is
highly expressed in neural tissue and has been hypothesized to play a role in energy homeostasis via neural pathways controlling food intake [51].
To our knowledge, both ELAVL4 (ELAV Like RNA Binding Protein 4) and SCGZ (Sarcoglycan zeta) loci have not been associated with smoking bahavior in GWAS. We examined the
GTEx database, and both ELAVL4 ad SGCZ are highly expressed in multiple brain tissues (Fig
5). The ELAVL4 gene is known to be associated with hallucinogen abuse, paraneoplastic
neurologic disorders, and Parkinson disease [52]. Although there was suggestive evidence of
association between SCGZ locus and BMI, it has not been considered as the GWAS BMI locus;
[20] however, a previous copy number variation (CNV) analysis in two African American populations had identified a CNV overlapping with SGCZ gene region to be signficantly associated
with BMI.[53] Previously, SGCZ and other genes invovled in cell adhesion processes were
linked to addiction vulnerability.[54] Cell adhesion mechanisms are central for properly establishing and regulating neuronal connections during development and can play major roles in
mnemonic processes in adults [55–57]. In addition to reward processes, there are growing
bodies of data implicating that cell-adhesion and related memory-like processes play important roles in substance dependence.[54,55,57,58]
Future studies of identification of pleiotropic genes on both BMI and smoking phenotypes
may focus on pathways of those candidate loci, in particular BDNF gene. Among 241 SNPs,
there was one SNP (rs3800229) in the locus of FOXO3 that can be inactivated by signaling pathways acctived by neurotrophins (such as BDNF).[59,60] This SNP was assciated with pack-years
in the OncoArray Project data and ever-smoking in TAG data with a nominal signficance of
p<0.05 (data not shown), but this SNP did not achived the cut-off to be classified into the pleiotropic categoriy. Nevertheless, our finding on associatons of BDNF suggests the regulatory pathway of BDNF and its other target loci may play a role in both smoking behavior and BMI.
In general, genetic variants, BMI and smoking phenotypes are in complex relationships. In
addtion to pleiotropic effects of genetic varaints on BMI and smoking phentoypes, there may
also be interactions between genetic variants and smokings on BMI. For example, a recent
study identified several novel BMI loci by accounting for SNP-smoking interactions. [61] In
the presence of such interaction, one would also expect assoications between a SNP and smoking status in BMI-based ascertained samples, although the SNPs is not associated with smoking
status in the general population. A future study fully accounting for these relationships may
reveal additional novel loci of obesity and smoking phenotypes.
In summary, we identified four potential loci that may have pleiotropic effects on BMI and
smoking traits. All four potential pleiotropic loci on BMI and smoking phenotypes are
expressed in the human brain, and prior experimental evidence indicates that these genes are
invovled in relevant complex brain functions, e.g. brain’s reward circutry and neural cell adhesion mechanisms. The biological functions of these genes support our findings. Future studies
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Fig 5. The gene expressions of ELAVL4 and SGCZ across different tissue in GTEx database. The bar shows the expression median and interalquartile
range in different tissues. The yellow bars repsent tissues in brain.
https://doi.org/10.1371/journal.pone.0185660.g005

of confirmation of these loci may suggest targets for searching new drugs for controlling smoking and eating behaviors. Sequencing these genes and other genes in relevant pathways may be
helpful for identifying funtional variants that have pleiotropic effects on both BMI and smoking behavior.
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